Mizuho healthcare sector expert Jared Holz explained: "Now without a GLP in its (near-term) pipeline, it is now feasible that PFE could look to bring in an asset (external business development) should it choose to stay in the weight-loss game to some extent." Anjalee Khemlani is the senior health reporter at Yahoo Finance, covering all things pharma, insurance, care services, digital health, PBMs, and health policy and politics
Type 2 diabetes preventive effects with a 12-months sardine-enriched diet in elderly population with prediabetes: an interventional, randomized and controlled trial
Diabetologia 67 , 24712480 (2024)
Results were presented at the 2025 EASD meeting and published in The New England Journal of Medicine
Ligand-specific factors influencing GLP-1 receptor post-endocytic trafficking and degradation in pancreatic beta cells
Over time, she had gained weight and used the drug to address that